Clinical Trials Logo

Gulf War Illness clinical trials

View clinical trials related to Gulf War Illness.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05252949 Active, not recruiting - Gulf War Illness Clinical Trials

OEA for Targeting Lipid Metabolism in GWI

Start date: June 10, 2021
Phase: N/A
Study type: Interventional

The study is a single site, randomized, double-blind, placebo-controlled study with an open label extension to evaluate the effects of Oleoylethanolamine (OEA) on blood lipid and immune biomarkers in participants with Gulf War Illness (GWI).

NCT ID: NCT03082638 Active, not recruiting - Gulf War Illness Clinical Trials

Identification of Gulf War Illness (GWI) Biomarkers

Start date: January 18, 2017
Phase:
Study type: Observational

The scientists working on this study want to use blood samples to identify components in blood, such as protein, lipids and their breakdown products to determine if they can be used for diagnosing Gulf War Illness (GWI). An additional goal is to examine the relationship of changes in these markers with the exposures and symptoms associated with GWI. The Scientists will also prepare RNA and DNA from the blood samples for genetic analyses of certain proteins known to increase the risk for GWI. This information will be one of the factors included in the analysis of results from the protein studies.